开云app官网登录入口网页版-官方正版

[GetPortalCommentsPageByObjectIdResponse(id=964224, encodeId=d19f96422486, content=偏重的研究方向：外泌体 ; 干细胞治疗 ; Tissue regeneration 经验分享：刚接收了一篇，出乎意料的快和顺利，一审20天，二审30天，两个月就接收了，感觉这个杂志比较好中，前面cell stem cell，stem cell reports，stem cells和ebiomedicine都是秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0gbVISGnicok3a1pkk9eJjGUG8JvN5oCPbpgzZ0gK3jcOMeNDmiajAUNfvf1vrSzgFDoKdibR60zVzdpBxBOs9cw/0, createdBy=83c82193682, createdName=krygios, createdTime=Mon May 10 10:00:20 CST 2021, time=2021-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2222761, encodeId=fc592222e615c, content=请问大家一审给了小修，返修后还会送外审吗，停在under review一个多月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05ba8241971, createdName=ms3000001959484884, createdTime=Wed Aug 28 01:38:31 CST 2024, time=2024-08-28, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2178708, encodeId=de9521e8708fe, content=偏重的研究方向：干细胞 经验分享：记录一下，怂怂怂 Submitted to Journal: 12 Dec 2023 Editor Assigned: 13 Dec 2023 Under Review: 25 Dec 2023 Reviews Completed: 31 Dec 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=27ff1606011, createdName=加油！, createdTime=Tue Jan 02 09:27:54 CST 2024, time=2024-01-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2223783, encodeId=8abe2223e832f, content=偏重的研究方向：differentiation;干细胞 经验分享：投稿周期5个月，7-8分的杂志，方向干细胞和分化，运气还不错，修回1次，补充说明2次，编辑态度也很好，老师的指导和回复都很给力，似乎有一种不真实感，但更多的是如释重负的感觉。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=518f5419672, createdName=ms6000000775525571, createdTime=Tue Sep 03 03:56:10 CST 2024, time=2024-09-03, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2216281, encodeId=31f7221628177, content=想问一下大家，文章已经under review到review completed停留了半个月之后，又变成reviewer assigned然后under view是什么情况呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f9a5457811, createdName=ms5000001675876209, createdTime=Mon Jul 22 15:46:11 CST 2024, time=2024-07-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2217102, encodeId=b597221e10239, content=能问一下现在这个杂志投稿，最后接收还需要原始数据么？24年7月，现在这边投稿的时候，就需要上传原始WB结果了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83er45pSGo36aicNSXobicEjlV1CQaGNfBykKqynqYcsqDPPiaEd4XPuJRyVDQ5bu9PqavBTndIjlnPS8w/132, createdBy=000b2274550, createdName=JYCVin, createdTime=Sat Jul 27 16:50:49 CST 2024, time=2024-07-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2147155, encodeId=99df214e1551e, content=2023.7.7号晚上刚刚接受了1篇，修了5次，共6个月零2天。此刊物2022发表380余篇，2021发表800余篇，共各位朋友参考。以往是accept之后很久才final accept，现在是接受前就反复check, accept之后1天就更新为final accept，那种接受后又因为数据审查不通过拒稿的现象应该少多了吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=57121645592, createdName=Zhudingding, createdTime=Sun Jul 09 19:02:37 CST 2023, time=2023-07-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2199856, encodeId=23122199856bd, content=偏重的研究方向：干细胞;间充质干细胞;干细胞治疗 经验分享：请问大家under review多久之后给的返修意见呀，我从投到送审大概一个半月的时间了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79479268384, createdName=ms7000000968424240, createdTime=Mon Apr 22 21:56:01 CST 2024, time=2024-04-22, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2186628, encodeId=c9a52186628d1, content=偏重的研究方向：干细胞;干细胞治疗 经验分享：想知道投的这个杂志的综述容易接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=165a8423903, createdName=ms4000002111139793, createdTime=Fri Feb 09 00:47:43 CST 2024, time=2024-02-09, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2142719, encodeId=71fc2142e1908, content=投稿后10天左右让修改了一下格式，提交了原始图片，现在已经整整一个月了，一直处于 editor assigned状态，投稿时间记录..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85e38686630, createdName=ms8000000826346257, createdTime=Wed Jun 14 11:43:51 CST 2023, time=2023-06-14, status=1, ipAttribution=山西省)]

2021-05-10 krygios

偏重的研究方向：外泌体 ; 干细胞治疗 ; Tissue regeneration
经验分享：刚接收了一篇，出乎意料的快和顺利，一审20天，二审30天，两个月就接收了，感觉这个杂志比较好中，前面cell stem cell，stem cell reports，stem cells和ebiomedicine都是秒拒

167 10

展开10条回复

[GetPortalCommentsPageByObjectIdResponse(id=964224, encodeId=d19f96422486, content=偏重的研究方向：外泌体 ; 干细胞治疗 ; Tissue regeneration 经验分享：刚接收了一篇，出乎意料的快和顺利，一审20天，二审30天，两个月就接收了，感觉这个杂志比较好中，前面cell stem cell，stem cell reports，stem cells和ebiomedicine都是秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0gbVISGnicok3a1pkk9eJjGUG8JvN5oCPbpgzZ0gK3jcOMeNDmiajAUNfvf1vrSzgFDoKdibR60zVzdpBxBOs9cw/0, createdBy=83c82193682, createdName=krygios, createdTime=Mon May 10 10:00:20 CST 2021, time=2021-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2222761, encodeId=fc592222e615c, content=请问大家一审给了小修，返修后还会送外审吗，停在under review一个多月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05ba8241971, createdName=ms3000001959484884, createdTime=Wed Aug 28 01:38:31 CST 2024, time=2024-08-28, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2178708, encodeId=de9521e8708fe, content=偏重的研究方向：干细胞 经验分享：记录一下，怂怂怂 Submitted to Journal: 12 Dec 2023 Editor Assigned: 13 Dec 2023 Under Review: 25 Dec 2023 Reviews Completed: 31 Dec 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=27ff1606011, createdName=加油！, createdTime=Tue Jan 02 09:27:54 CST 2024, time=2024-01-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2223783, encodeId=8abe2223e832f, content=偏重的研究方向：differentiation;干细胞 经验分享：投稿周期5个月，7-8分的杂志，方向干细胞和分化，运气还不错，修回1次，补充说明2次，编辑态度也很好，老师的指导和回复都很给力，似乎有一种不真实感，但更多的是如释重负的感觉。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=518f5419672, createdName=ms6000000775525571, createdTime=Tue Sep 03 03:56:10 CST 2024, time=2024-09-03, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2216281, encodeId=31f7221628177, content=想问一下大家，文章已经under review到review completed停留了半个月之后，又变成reviewer assigned然后under view是什么情况呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f9a5457811, createdName=ms5000001675876209, createdTime=Mon Jul 22 15:46:11 CST 2024, time=2024-07-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2217102, encodeId=b597221e10239, content=能问一下现在这个杂志投稿，最后接收还需要原始数据么？24年7月，现在这边投稿的时候，就需要上传原始WB结果了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83er45pSGo36aicNSXobicEjlV1CQaGNfBykKqynqYcsqDPPiaEd4XPuJRyVDQ5bu9PqavBTndIjlnPS8w/132, createdBy=000b2274550, createdName=JYCVin, createdTime=Sat Jul 27 16:50:49 CST 2024, time=2024-07-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2147155, encodeId=99df214e1551e, content=2023.7.7号晚上刚刚接受了1篇，修了5次，共6个月零2天。此刊物2022发表380余篇，2021发表800余篇，共各位朋友参考。以往是accept之后很久才final accept，现在是接受前就反复check, accept之后1天就更新为final accept，那种接受后又因为数据审查不通过拒稿的现象应该少多了吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=57121645592, createdName=Zhudingding, createdTime=Sun Jul 09 19:02:37 CST 2023, time=2023-07-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2199856, encodeId=23122199856bd, content=偏重的研究方向：干细胞;间充质干细胞;干细胞治疗 经验分享：请问大家under review多久之后给的返修意见呀，我从投到送审大概一个半月的时间了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79479268384, createdName=ms7000000968424240, createdTime=Mon Apr 22 21:56:01 CST 2024, time=2024-04-22, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2186628, encodeId=c9a52186628d1, content=偏重的研究方向：干细胞;干细胞治疗 经验分享：想知道投的这个杂志的综述容易接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=165a8423903, createdName=ms4000002111139793, createdTime=Fri Feb 09 00:47:43 CST 2024, time=2024-02-09, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2142719, encodeId=71fc2142e1908, content=投稿后10天左右让修改了一下格式，提交了原始图片，现在已经整整一个月了，一直处于 editor assigned状态，投稿时间记录..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85e38686630, createdName=ms8000000826346257, createdTime=Wed Jun 14 11:43:51 CST 2023, time=2023-06-14, status=1, ipAttribution=山西省)]

2024-08-28 ms3000001959484884 来自江苏省

请问大家一审给了小修，返修后还会送外审吗，停在under review一个多月了

28 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=964224, encodeId=d19f96422486, content=偏重的研究方向：外泌体 ; 干细胞治疗 ; Tissue regeneration 经验分享：刚接收了一篇，出乎意料的快和顺利，一审20天，二审30天，两个月就接收了，感觉这个杂志比较好中，前面cell stem cell，stem cell reports，stem cells和ebiomedicine都是秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0gbVISGnicok3a1pkk9eJjGUG8JvN5oCPbpgzZ0gK3jcOMeNDmiajAUNfvf1vrSzgFDoKdibR60zVzdpBxBOs9cw/0, createdBy=83c82193682, createdName=krygios, createdTime=Mon May 10 10:00:20 CST 2021, time=2021-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2222761, encodeId=fc592222e615c, content=请问大家一审给了小修，返修后还会送外审吗，停在under review一个多月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05ba8241971, createdName=ms3000001959484884, createdTime=Wed Aug 28 01:38:31 CST 2024, time=2024-08-28, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2178708, encodeId=de9521e8708fe, content=偏重的研究方向：干细胞 经验分享：记录一下，怂怂怂 Submitted to Journal: 12 Dec 2023 Editor Assigned: 13 Dec 2023 Under Review: 25 Dec 2023 Reviews Completed: 31 Dec 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=27ff1606011, createdName=加油！, createdTime=Tue Jan 02 09:27:54 CST 2024, time=2024-01-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2223783, encodeId=8abe2223e832f, content=偏重的研究方向：differentiation;干细胞 经验分享：投稿周期5个月，7-8分的杂志，方向干细胞和分化，运气还不错，修回1次，补充说明2次，编辑态度也很好，老师的指导和回复都很给力，似乎有一种不真实感，但更多的是如释重负的感觉。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=518f5419672, createdName=ms6000000775525571, createdTime=Tue Sep 03 03:56:10 CST 2024, time=2024-09-03, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2216281, encodeId=31f7221628177, content=想问一下大家，文章已经under review到review completed停留了半个月之后，又变成reviewer assigned然后under view是什么情况呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f9a5457811, createdName=ms5000001675876209, createdTime=Mon Jul 22 15:46:11 CST 2024, time=2024-07-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2217102, encodeId=b597221e10239, content=能问一下现在这个杂志投稿，最后接收还需要原始数据么？24年7月，现在这边投稿的时候，就需要上传原始WB结果了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83er45pSGo36aicNSXobicEjlV1CQaGNfBykKqynqYcsqDPPiaEd4XPuJRyVDQ5bu9PqavBTndIjlnPS8w/132, createdBy=000b2274550, createdName=JYCVin, createdTime=Sat Jul 27 16:50:49 CST 2024, time=2024-07-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2147155, encodeId=99df214e1551e, content=2023.7.7号晚上刚刚接受了1篇，修了5次，共6个月零2天。此刊物2022发表380余篇，2021发表800余篇，共各位朋友参考。以往是accept之后很久才final accept，现在是接受前就反复check, accept之后1天就更新为final accept，那种接受后又因为数据审查不通过拒稿的现象应该少多了吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=57121645592, createdName=Zhudingding, createdTime=Sun Jul 09 19:02:37 CST 2023, time=2023-07-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2199856, encodeId=23122199856bd, content=偏重的研究方向：干细胞;间充质干细胞;干细胞治疗 经验分享：请问大家under review多久之后给的返修意见呀，我从投到送审大概一个半月的时间了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79479268384, createdName=ms7000000968424240, createdTime=Mon Apr 22 21:56:01 CST 2024, time=2024-04-22, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2186628, encodeId=c9a52186628d1, content=偏重的研究方向：干细胞;干细胞治疗 经验分享：想知道投的这个杂志的综述容易接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=165a8423903, createdName=ms4000002111139793, createdTime=Fri Feb 09 00:47:43 CST 2024, time=2024-02-09, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2142719, encodeId=71fc2142e1908, content=投稿后10天左右让修改了一下格式，提交了原始图片，现在已经整整一个月了，一直处于 editor assigned状态，投稿时间记录..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85e38686630, createdName=ms8000000826346257, createdTime=Wed Jun 14 11:43:51 CST 2023, time=2023-06-14, status=1, ipAttribution=山西省)]

2024-01-02 加油！来自江苏省

偏重的研究方向：干细胞
经验分享：记录一下，怂怂怂
Submitted to Journal: 12 Dec 2023
Editor Assigned: 13 Dec 2023
Under Review: 25 Dec 2023
Reviews Completed: 31 Dec 2023

81 8

展开8条回复

[GetPortalCommentsPageByObjectIdResponse(id=964224, encodeId=d19f96422486, content=偏重的研究方向：外泌体 ; 干细胞治疗 ; Tissue regeneration 经验分享：刚接收了一篇，出乎意料的快和顺利，一审20天，二审30天，两个月就接收了，感觉这个杂志比较好中，前面cell stem cell，stem cell reports，stem cells和ebiomedicine都是秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0gbVISGnicok3a1pkk9eJjGUG8JvN5oCPbpgzZ0gK3jcOMeNDmiajAUNfvf1vrSzgFDoKdibR60zVzdpBxBOs9cw/0, createdBy=83c82193682, createdName=krygios, createdTime=Mon May 10 10:00:20 CST 2021, time=2021-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2222761, encodeId=fc592222e615c, content=请问大家一审给了小修，返修后还会送外审吗，停在under review一个多月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05ba8241971, createdName=ms3000001959484884, createdTime=Wed Aug 28 01:38:31 CST 2024, time=2024-08-28, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2178708, encodeId=de9521e8708fe, content=偏重的研究方向：干细胞 经验分享：记录一下，怂怂怂 Submitted to Journal: 12 Dec 2023 Editor Assigned: 13 Dec 2023 Under Review: 25 Dec 2023 Reviews Completed: 31 Dec 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=27ff1606011, createdName=加油！, createdTime=Tue Jan 02 09:27:54 CST 2024, time=2024-01-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2223783, encodeId=8abe2223e832f, content=偏重的研究方向：differentiation;干细胞 经验分享：投稿周期5个月，7-8分的杂志，方向干细胞和分化，运气还不错，修回1次，补充说明2次，编辑态度也很好，老师的指导和回复都很给力，似乎有一种不真实感，但更多的是如释重负的感觉。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=518f5419672, createdName=ms6000000775525571, createdTime=Tue Sep 03 03:56:10 CST 2024, time=2024-09-03, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2216281, encodeId=31f7221628177, content=想问一下大家，文章已经under review到review completed停留了半个月之后，又变成reviewer assigned然后under view是什么情况呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f9a5457811, createdName=ms5000001675876209, createdTime=Mon Jul 22 15:46:11 CST 2024, time=2024-07-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2217102, encodeId=b597221e10239, content=能问一下现在这个杂志投稿，最后接收还需要原始数据么？24年7月，现在这边投稿的时候，就需要上传原始WB结果了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83er45pSGo36aicNSXobicEjlV1CQaGNfBykKqynqYcsqDPPiaEd4XPuJRyVDQ5bu9PqavBTndIjlnPS8w/132, createdBy=000b2274550, createdName=JYCVin, createdTime=Sat Jul 27 16:50:49 CST 2024, time=2024-07-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2147155, encodeId=99df214e1551e, content=2023.7.7号晚上刚刚接受了1篇，修了5次，共6个月零2天。此刊物2022发表380余篇，2021发表800余篇，共各位朋友参考。以往是accept之后很久才final accept，现在是接受前就反复check, accept之后1天就更新为final accept，那种接受后又因为数据审查不通过拒稿的现象应该少多了吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=57121645592, createdName=Zhudingding, createdTime=Sun Jul 09 19:02:37 CST 2023, time=2023-07-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2199856, encodeId=23122199856bd, content=偏重的研究方向：干细胞;间充质干细胞;干细胞治疗 经验分享：请问大家under review多久之后给的返修意见呀，我从投到送审大概一个半月的时间了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79479268384, createdName=ms7000000968424240, createdTime=Mon Apr 22 21:56:01 CST 2024, time=2024-04-22, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2186628, encodeId=c9a52186628d1, content=偏重的研究方向：干细胞;干细胞治疗 经验分享：想知道投的这个杂志的综述容易接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=165a8423903, createdName=ms4000002111139793, createdTime=Fri Feb 09 00:47:43 CST 2024, time=2024-02-09, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2142719, encodeId=71fc2142e1908, content=投稿后10天左右让修改了一下格式，提交了原始图片，现在已经整整一个月了，一直处于 editor assigned状态，投稿时间记录..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85e38686630, createdName=ms8000000826346257, createdTime=Wed Jun 14 11:43:51 CST 2023, time=2023-06-14, status=1, ipAttribution=山西省)]

2024-09-03 ms6000000775525571 来自湖北省

偏重的研究方向：differentiation;干细胞
经验分享：投稿周期5个月，7-8分的杂志，方向干细胞和分化，运气还不错，修回1次，补充说明2次，编辑态度也很好，老师的指导和回复都很给力，似乎有一种不真实感，但更多的是如释重负的感觉。

15 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=964224, encodeId=d19f96422486, content=偏重的研究方向：外泌体 ; 干细胞治疗 ; Tissue regeneration 经验分享：刚接收了一篇，出乎意料的快和顺利，一审20天，二审30天，两个月就接收了，感觉这个杂志比较好中，前面cell stem cell，stem cell reports，stem cells和ebiomedicine都是秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0gbVISGnicok3a1pkk9eJjGUG8JvN5oCPbpgzZ0gK3jcOMeNDmiajAUNfvf1vrSzgFDoKdibR60zVzdpBxBOs9cw/0, createdBy=83c82193682, createdName=krygios, createdTime=Mon May 10 10:00:20 CST 2021, time=2021-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2222761, encodeId=fc592222e615c, content=请问大家一审给了小修，返修后还会送外审吗，停在under review一个多月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05ba8241971, createdName=ms3000001959484884, createdTime=Wed Aug 28 01:38:31 CST 2024, time=2024-08-28, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2178708, encodeId=de9521e8708fe, content=偏重的研究方向：干细胞 经验分享：记录一下，怂怂怂 Submitted to Journal: 12 Dec 2023 Editor Assigned: 13 Dec 2023 Under Review: 25 Dec 2023 Reviews Completed: 31 Dec 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=27ff1606011, createdName=加油！, createdTime=Tue Jan 02 09:27:54 CST 2024, time=2024-01-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2223783, encodeId=8abe2223e832f, content=偏重的研究方向：differentiation;干细胞 经验分享：投稿周期5个月，7-8分的杂志，方向干细胞和分化，运气还不错，修回1次，补充说明2次，编辑态度也很好，老师的指导和回复都很给力，似乎有一种不真实感，但更多的是如释重负的感觉。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=518f5419672, createdName=ms6000000775525571, createdTime=Tue Sep 03 03:56:10 CST 2024, time=2024-09-03, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2216281, encodeId=31f7221628177, content=想问一下大家，文章已经under review到review completed停留了半个月之后，又变成reviewer assigned然后under view是什么情况呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f9a5457811, createdName=ms5000001675876209, createdTime=Mon Jul 22 15:46:11 CST 2024, time=2024-07-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2217102, encodeId=b597221e10239, content=能问一下现在这个杂志投稿，最后接收还需要原始数据么？24年7月，现在这边投稿的时候，就需要上传原始WB结果了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83er45pSGo36aicNSXobicEjlV1CQaGNfBykKqynqYcsqDPPiaEd4XPuJRyVDQ5bu9PqavBTndIjlnPS8w/132, createdBy=000b2274550, createdName=JYCVin, createdTime=Sat Jul 27 16:50:49 CST 2024, time=2024-07-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2147155, encodeId=99df214e1551e, content=2023.7.7号晚上刚刚接受了1篇，修了5次，共6个月零2天。此刊物2022发表380余篇，2021发表800余篇，共各位朋友参考。以往是accept之后很久才final accept，现在是接受前就反复check, accept之后1天就更新为final accept，那种接受后又因为数据审查不通过拒稿的现象应该少多了吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=57121645592, createdName=Zhudingding, createdTime=Sun Jul 09 19:02:37 CST 2023, time=2023-07-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2199856, encodeId=23122199856bd, content=偏重的研究方向：干细胞;间充质干细胞;干细胞治疗 经验分享：请问大家under review多久之后给的返修意见呀，我从投到送审大概一个半月的时间了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79479268384, createdName=ms7000000968424240, createdTime=Mon Apr 22 21:56:01 CST 2024, time=2024-04-22, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2186628, encodeId=c9a52186628d1, content=偏重的研究方向：干细胞;干细胞治疗 经验分享：想知道投的这个杂志的综述容易接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=165a8423903, createdName=ms4000002111139793, createdTime=Fri Feb 09 00:47:43 CST 2024, time=2024-02-09, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2142719, encodeId=71fc2142e1908, content=投稿后10天左右让修改了一下格式，提交了原始图片，现在已经整整一个月了，一直处于 editor assigned状态，投稿时间记录..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85e38686630, createdName=ms8000000826346257, createdTime=Wed Jun 14 11:43:51 CST 2023, time=2023-06-14, status=1, ipAttribution=山西省)]

2024-07-22 ms5000001675876209 来自广东省

想问一下大家，文章已经under review到review completed停留了半个月之后，又变成reviewer assigned然后under view是什么情况呀？

81 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=964224, encodeId=d19f96422486, content=偏重的研究方向：外泌体 ; 干细胞治疗 ; Tissue regeneration 经验分享：刚接收了一篇，出乎意料的快和顺利，一审20天，二审30天，两个月就接收了，感觉这个杂志比较好中，前面cell stem cell，stem cell reports，stem cells和ebiomedicine都是秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0gbVISGnicok3a1pkk9eJjGUG8JvN5oCPbpgzZ0gK3jcOMeNDmiajAUNfvf1vrSzgFDoKdibR60zVzdpBxBOs9cw/0, createdBy=83c82193682, createdName=krygios, createdTime=Mon May 10 10:00:20 CST 2021, time=2021-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2222761, encodeId=fc592222e615c, content=请问大家一审给了小修，返修后还会送外审吗，停在under review一个多月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05ba8241971, createdName=ms3000001959484884, createdTime=Wed Aug 28 01:38:31 CST 2024, time=2024-08-28, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2178708, encodeId=de9521e8708fe, content=偏重的研究方向：干细胞 经验分享：记录一下，怂怂怂 Submitted to Journal: 12 Dec 2023 Editor Assigned: 13 Dec 2023 Under Review: 25 Dec 2023 Reviews Completed: 31 Dec 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=27ff1606011, createdName=加油！, createdTime=Tue Jan 02 09:27:54 CST 2024, time=2024-01-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2223783, encodeId=8abe2223e832f, content=偏重的研究方向：differentiation;干细胞 经验分享：投稿周期5个月，7-8分的杂志，方向干细胞和分化，运气还不错，修回1次，补充说明2次，编辑态度也很好，老师的指导和回复都很给力，似乎有一种不真实感，但更多的是如释重负的感觉。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=518f5419672, createdName=ms6000000775525571, createdTime=Tue Sep 03 03:56:10 CST 2024, time=2024-09-03, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2216281, encodeId=31f7221628177, content=想问一下大家，文章已经under review到review completed停留了半个月之后，又变成reviewer assigned然后under view是什么情况呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f9a5457811, createdName=ms5000001675876209, createdTime=Mon Jul 22 15:46:11 CST 2024, time=2024-07-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2217102, encodeId=b597221e10239, content=能问一下现在这个杂志投稿，最后接收还需要原始数据么？24年7月，现在这边投稿的时候，就需要上传原始WB结果了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83er45pSGo36aicNSXobicEjlV1CQaGNfBykKqynqYcsqDPPiaEd4XPuJRyVDQ5bu9PqavBTndIjlnPS8w/132, createdBy=000b2274550, createdName=JYCVin, createdTime=Sat Jul 27 16:50:49 CST 2024, time=2024-07-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2147155, encodeId=99df214e1551e, content=2023.7.7号晚上刚刚接受了1篇，修了5次，共6个月零2天。此刊物2022发表380余篇，2021发表800余篇，共各位朋友参考。以往是accept之后很久才final accept，现在是接受前就反复check, accept之后1天就更新为final accept，那种接受后又因为数据审查不通过拒稿的现象应该少多了吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=57121645592, createdName=Zhudingding, createdTime=Sun Jul 09 19:02:37 CST 2023, time=2023-07-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2199856, encodeId=23122199856bd, content=偏重的研究方向：干细胞;间充质干细胞;干细胞治疗 经验分享：请问大家under review多久之后给的返修意见呀，我从投到送审大概一个半月的时间了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79479268384, createdName=ms7000000968424240, createdTime=Mon Apr 22 21:56:01 CST 2024, time=2024-04-22, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2186628, encodeId=c9a52186628d1, content=偏重的研究方向：干细胞;干细胞治疗 经验分享：想知道投的这个杂志的综述容易接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=165a8423903, createdName=ms4000002111139793, createdTime=Fri Feb 09 00:47:43 CST 2024, time=2024-02-09, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2142719, encodeId=71fc2142e1908, content=投稿后10天左右让修改了一下格式，提交了原始图片，现在已经整整一个月了，一直处于 editor assigned状态，投稿时间记录..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85e38686630, createdName=ms8000000826346257, createdTime=Wed Jun 14 11:43:51 CST 2023, time=2023-06-14, status=1, ipAttribution=山西省)]

2024-07-27 JYCVin 来自浙江省

能问一下现在这个杂志投稿，最后接收还需要原始数据么？24年7月，现在这边投稿的时候，就需要上传原始WB结果了。

47 0

[GetPortalCommentsPageByObjectIdResponse(id=964224, encodeId=d19f96422486, content=偏重的研究方向：外泌体 ; 干细胞治疗 ; Tissue regeneration 经验分享：刚接收了一篇，出乎意料的快和顺利，一审20天，二审30天，两个月就接收了，感觉这个杂志比较好中，前面cell stem cell，stem cell reports，stem cells和ebiomedicine都是秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0gbVISGnicok3a1pkk9eJjGUG8JvN5oCPbpgzZ0gK3jcOMeNDmiajAUNfvf1vrSzgFDoKdibR60zVzdpBxBOs9cw/0, createdBy=83c82193682, createdName=krygios, createdTime=Mon May 10 10:00:20 CST 2021, time=2021-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2222761, encodeId=fc592222e615c, content=请问大家一审给了小修，返修后还会送外审吗，停在under review一个多月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05ba8241971, createdName=ms3000001959484884, createdTime=Wed Aug 28 01:38:31 CST 2024, time=2024-08-28, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2178708, encodeId=de9521e8708fe, content=偏重的研究方向：干细胞 经验分享：记录一下，怂怂怂 Submitted to Journal: 12 Dec 2023 Editor Assigned: 13 Dec 2023 Under Review: 25 Dec 2023 Reviews Completed: 31 Dec 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=27ff1606011, createdName=加油！, createdTime=Tue Jan 02 09:27:54 CST 2024, time=2024-01-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2223783, encodeId=8abe2223e832f, content=偏重的研究方向：differentiation;干细胞 经验分享：投稿周期5个月，7-8分的杂志，方向干细胞和分化，运气还不错，修回1次，补充说明2次，编辑态度也很好，老师的指导和回复都很给力，似乎有一种不真实感，但更多的是如释重负的感觉。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=518f5419672, createdName=ms6000000775525571, createdTime=Tue Sep 03 03:56:10 CST 2024, time=2024-09-03, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2216281, encodeId=31f7221628177, content=想问一下大家，文章已经under review到review completed停留了半个月之后，又变成reviewer assigned然后under view是什么情况呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f9a5457811, createdName=ms5000001675876209, createdTime=Mon Jul 22 15:46:11 CST 2024, time=2024-07-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2217102, encodeId=b597221e10239, content=能问一下现在这个杂志投稿，最后接收还需要原始数据么？24年7月，现在这边投稿的时候，就需要上传原始WB结果了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83er45pSGo36aicNSXobicEjlV1CQaGNfBykKqynqYcsqDPPiaEd4XPuJRyVDQ5bu9PqavBTndIjlnPS8w/132, createdBy=000b2274550, createdName=JYCVin, createdTime=Sat Jul 27 16:50:49 CST 2024, time=2024-07-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2147155, encodeId=99df214e1551e, content=2023.7.7号晚上刚刚接受了1篇，修了5次，共6个月零2天。此刊物2022发表380余篇，2021发表800余篇，共各位朋友参考。以往是accept之后很久才final accept，现在是接受前就反复check, accept之后1天就更新为final accept，那种接受后又因为数据审查不通过拒稿的现象应该少多了吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=57121645592, createdName=Zhudingding, createdTime=Sun Jul 09 19:02:37 CST 2023, time=2023-07-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2199856, encodeId=23122199856bd, content=偏重的研究方向：干细胞;间充质干细胞;干细胞治疗 经验分享：请问大家under review多久之后给的返修意见呀，我从投到送审大概一个半月的时间了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79479268384, createdName=ms7000000968424240, createdTime=Mon Apr 22 21:56:01 CST 2024, time=2024-04-22, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2186628, encodeId=c9a52186628d1, content=偏重的研究方向：干细胞;干细胞治疗 经验分享：想知道投的这个杂志的综述容易接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=165a8423903, createdName=ms4000002111139793, createdTime=Fri Feb 09 00:47:43 CST 2024, time=2024-02-09, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2142719, encodeId=71fc2142e1908, content=投稿后10天左右让修改了一下格式，提交了原始图片，现在已经整整一个月了，一直处于 editor assigned状态，投稿时间记录..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85e38686630, createdName=ms8000000826346257, createdTime=Wed Jun 14 11:43:51 CST 2023, time=2023-06-14, status=1, ipAttribution=山西省)]

2023-07-09 Zhudingding 来自北京

2023.7.7号晚上刚刚接受了1篇，修了5次，共6个月零2天。此刊物2022发表380余篇，2021发表800余篇，共各位朋友参考。以往是accept之后很久才final accept，现在是接受前就反复check, accept之后1天就更新为final accept，那种接受后又因为数据审查不通过拒稿的现象应该少多了吧。

112 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=964224, encodeId=d19f96422486, content=偏重的研究方向：外泌体 ; 干细胞治疗 ; Tissue regeneration 经验分享：刚接收了一篇，出乎意料的快和顺利，一审20天，二审30天，两个月就接收了，感觉这个杂志比较好中，前面cell stem cell，stem cell reports，stem cells和ebiomedicine都是秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0gbVISGnicok3a1pkk9eJjGUG8JvN5oCPbpgzZ0gK3jcOMeNDmiajAUNfvf1vrSzgFDoKdibR60zVzdpBxBOs9cw/0, createdBy=83c82193682, createdName=krygios, createdTime=Mon May 10 10:00:20 CST 2021, time=2021-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2222761, encodeId=fc592222e615c, content=请问大家一审给了小修，返修后还会送外审吗，停在under review一个多月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05ba8241971, createdName=ms3000001959484884, createdTime=Wed Aug 28 01:38:31 CST 2024, time=2024-08-28, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2178708, encodeId=de9521e8708fe, content=偏重的研究方向：干细胞 经验分享：记录一下，怂怂怂 Submitted to Journal: 12 Dec 2023 Editor Assigned: 13 Dec 2023 Under Review: 25 Dec 2023 Reviews Completed: 31 Dec 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=27ff1606011, createdName=加油！, createdTime=Tue Jan 02 09:27:54 CST 2024, time=2024-01-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2223783, encodeId=8abe2223e832f, content=偏重的研究方向：differentiation;干细胞 经验分享：投稿周期5个月，7-8分的杂志，方向干细胞和分化，运气还不错，修回1次，补充说明2次，编辑态度也很好，老师的指导和回复都很给力，似乎有一种不真实感，但更多的是如释重负的感觉。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=518f5419672, createdName=ms6000000775525571, createdTime=Tue Sep 03 03:56:10 CST 2024, time=2024-09-03, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2216281, encodeId=31f7221628177, content=想问一下大家，文章已经under review到review completed停留了半个月之后，又变成reviewer assigned然后under view是什么情况呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f9a5457811, createdName=ms5000001675876209, createdTime=Mon Jul 22 15:46:11 CST 2024, time=2024-07-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2217102, encodeId=b597221e10239, content=能问一下现在这个杂志投稿，最后接收还需要原始数据么？24年7月，现在这边投稿的时候，就需要上传原始WB结果了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83er45pSGo36aicNSXobicEjlV1CQaGNfBykKqynqYcsqDPPiaEd4XPuJRyVDQ5bu9PqavBTndIjlnPS8w/132, createdBy=000b2274550, createdName=JYCVin, createdTime=Sat Jul 27 16:50:49 CST 2024, time=2024-07-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2147155, encodeId=99df214e1551e, content=2023.7.7号晚上刚刚接受了1篇，修了5次，共6个月零2天。此刊物2022发表380余篇，2021发表800余篇，共各位朋友参考。以往是accept之后很久才final accept，现在是接受前就反复check, accept之后1天就更新为final accept，那种接受后又因为数据审查不通过拒稿的现象应该少多了吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=57121645592, createdName=Zhudingding, createdTime=Sun Jul 09 19:02:37 CST 2023, time=2023-07-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2199856, encodeId=23122199856bd, content=偏重的研究方向：干细胞;间充质干细胞;干细胞治疗 经验分享：请问大家under review多久之后给的返修意见呀，我从投到送审大概一个半月的时间了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79479268384, createdName=ms7000000968424240, createdTime=Mon Apr 22 21:56:01 CST 2024, time=2024-04-22, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2186628, encodeId=c9a52186628d1, content=偏重的研究方向：干细胞;干细胞治疗 经验分享：想知道投的这个杂志的综述容易接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=165a8423903, createdName=ms4000002111139793, createdTime=Fri Feb 09 00:47:43 CST 2024, time=2024-02-09, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2142719, encodeId=71fc2142e1908, content=投稿后10天左右让修改了一下格式，提交了原始图片，现在已经整整一个月了，一直处于 editor assigned状态，投稿时间记录..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85e38686630, createdName=ms8000000826346257, createdTime=Wed Jun 14 11:43:51 CST 2023, time=2023-06-14, status=1, ipAttribution=山西省)]

2024-04-22 ms7000000968424240 来自江苏省

偏重的研究方向：干细胞;间充质干细胞;干细胞治疗
经验分享：请问大家under review多久之后给的返修意见呀，我从投到送审大概一个半月的时间了。

64 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=964224, encodeId=d19f96422486, content=偏重的研究方向：外泌体 ; 干细胞治疗 ; Tissue regeneration 经验分享：刚接收了一篇，出乎意料的快和顺利，一审20天，二审30天，两个月就接收了，感觉这个杂志比较好中，前面cell stem cell，stem cell reports，stem cells和ebiomedicine都是秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0gbVISGnicok3a1pkk9eJjGUG8JvN5oCPbpgzZ0gK3jcOMeNDmiajAUNfvf1vrSzgFDoKdibR60zVzdpBxBOs9cw/0, createdBy=83c82193682, createdName=krygios, createdTime=Mon May 10 10:00:20 CST 2021, time=2021-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2222761, encodeId=fc592222e615c, content=请问大家一审给了小修，返修后还会送外审吗，停在under review一个多月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05ba8241971, createdName=ms3000001959484884, createdTime=Wed Aug 28 01:38:31 CST 2024, time=2024-08-28, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2178708, encodeId=de9521e8708fe, content=偏重的研究方向：干细胞 经验分享：记录一下，怂怂怂 Submitted to Journal: 12 Dec 2023 Editor Assigned: 13 Dec 2023 Under Review: 25 Dec 2023 Reviews Completed: 31 Dec 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=27ff1606011, createdName=加油！, createdTime=Tue Jan 02 09:27:54 CST 2024, time=2024-01-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2223783, encodeId=8abe2223e832f, content=偏重的研究方向：differentiation;干细胞 经验分享：投稿周期5个月，7-8分的杂志，方向干细胞和分化，运气还不错，修回1次，补充说明2次，编辑态度也很好，老师的指导和回复都很给力，似乎有一种不真实感，但更多的是如释重负的感觉。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=518f5419672, createdName=ms6000000775525571, createdTime=Tue Sep 03 03:56:10 CST 2024, time=2024-09-03, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2216281, encodeId=31f7221628177, content=想问一下大家，文章已经under review到review completed停留了半个月之后，又变成reviewer assigned然后under view是什么情况呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f9a5457811, createdName=ms5000001675876209, createdTime=Mon Jul 22 15:46:11 CST 2024, time=2024-07-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2217102, encodeId=b597221e10239, content=能问一下现在这个杂志投稿，最后接收还需要原始数据么？24年7月，现在这边投稿的时候，就需要上传原始WB结果了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83er45pSGo36aicNSXobicEjlV1CQaGNfBykKqynqYcsqDPPiaEd4XPuJRyVDQ5bu9PqavBTndIjlnPS8w/132, createdBy=000b2274550, createdName=JYCVin, createdTime=Sat Jul 27 16:50:49 CST 2024, time=2024-07-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2147155, encodeId=99df214e1551e, content=2023.7.7号晚上刚刚接受了1篇，修了5次，共6个月零2天。此刊物2022发表380余篇，2021发表800余篇，共各位朋友参考。以往是accept之后很久才final accept，现在是接受前就反复check, accept之后1天就更新为final accept，那种接受后又因为数据审查不通过拒稿的现象应该少多了吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=57121645592, createdName=Zhudingding, createdTime=Sun Jul 09 19:02:37 CST 2023, time=2023-07-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2199856, encodeId=23122199856bd, content=偏重的研究方向：干细胞;间充质干细胞;干细胞治疗 经验分享：请问大家under review多久之后给的返修意见呀，我从投到送审大概一个半月的时间了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79479268384, createdName=ms7000000968424240, createdTime=Mon Apr 22 21:56:01 CST 2024, time=2024-04-22, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2186628, encodeId=c9a52186628d1, content=偏重的研究方向：干细胞;干细胞治疗 经验分享：想知道投的这个杂志的综述容易接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=165a8423903, createdName=ms4000002111139793, createdTime=Fri Feb 09 00:47:43 CST 2024, time=2024-02-09, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2142719, encodeId=71fc2142e1908, content=投稿后10天左右让修改了一下格式，提交了原始图片，现在已经整整一个月了，一直处于 editor assigned状态，投稿时间记录..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85e38686630, createdName=ms8000000826346257, createdTime=Wed Jun 14 11:43:51 CST 2023, time=2023-06-14, status=1, ipAttribution=山西省)]

2024-02-09 ms4000002111139793 来自山西省

偏重的研究方向：干细胞;干细胞治疗
经验分享：想知道投的这个杂志的综述容易接收吗

86 0

[GetPortalCommentsPageByObjectIdResponse(id=964224, encodeId=d19f96422486, content=偏重的研究方向：外泌体 ; 干细胞治疗 ; Tissue regeneration 经验分享：刚接收了一篇，出乎意料的快和顺利，一审20天，二审30天，两个月就接收了，感觉这个杂志比较好中，前面cell stem cell，stem cell reports，stem cells和ebiomedicine都是秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0gbVISGnicok3a1pkk9eJjGUG8JvN5oCPbpgzZ0gK3jcOMeNDmiajAUNfvf1vrSzgFDoKdibR60zVzdpBxBOs9cw/0, createdBy=83c82193682, createdName=krygios, createdTime=Mon May 10 10:00:20 CST 2021, time=2021-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2222761, encodeId=fc592222e615c, content=请问大家一审给了小修，返修后还会送外审吗，停在under review一个多月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05ba8241971, createdName=ms3000001959484884, createdTime=Wed Aug 28 01:38:31 CST 2024, time=2024-08-28, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2178708, encodeId=de9521e8708fe, content=偏重的研究方向：干细胞 经验分享：记录一下，怂怂怂 Submitted to Journal: 12 Dec 2023 Editor Assigned: 13 Dec 2023 Under Review: 25 Dec 2023 Reviews Completed: 31 Dec 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=27ff1606011, createdName=加油！, createdTime=Tue Jan 02 09:27:54 CST 2024, time=2024-01-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2223783, encodeId=8abe2223e832f, content=偏重的研究方向：differentiation;干细胞 经验分享：投稿周期5个月，7-8分的杂志，方向干细胞和分化，运气还不错，修回1次，补充说明2次，编辑态度也很好，老师的指导和回复都很给力，似乎有一种不真实感，但更多的是如释重负的感觉。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=518f5419672, createdName=ms6000000775525571, createdTime=Tue Sep 03 03:56:10 CST 2024, time=2024-09-03, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2216281, encodeId=31f7221628177, content=想问一下大家，文章已经under review到review completed停留了半个月之后，又变成reviewer assigned然后under view是什么情况呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f9a5457811, createdName=ms5000001675876209, createdTime=Mon Jul 22 15:46:11 CST 2024, time=2024-07-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2217102, encodeId=b597221e10239, content=能问一下现在这个杂志投稿，最后接收还需要原始数据么？24年7月，现在这边投稿的时候，就需要上传原始WB结果了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83er45pSGo36aicNSXobicEjlV1CQaGNfBykKqynqYcsqDPPiaEd4XPuJRyVDQ5bu9PqavBTndIjlnPS8w/132, createdBy=000b2274550, createdName=JYCVin, createdTime=Sat Jul 27 16:50:49 CST 2024, time=2024-07-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2147155, encodeId=99df214e1551e, content=2023.7.7号晚上刚刚接受了1篇，修了5次，共6个月零2天。此刊物2022发表380余篇，2021发表800余篇，共各位朋友参考。以往是accept之后很久才final accept，现在是接受前就反复check, accept之后1天就更新为final accept，那种接受后又因为数据审查不通过拒稿的现象应该少多了吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=57121645592, createdName=Zhudingding, createdTime=Sun Jul 09 19:02:37 CST 2023, time=2023-07-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2199856, encodeId=23122199856bd, content=偏重的研究方向：干细胞;间充质干细胞;干细胞治疗 经验分享：请问大家under review多久之后给的返修意见呀，我从投到送审大概一个半月的时间了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79479268384, createdName=ms7000000968424240, createdTime=Mon Apr 22 21:56:01 CST 2024, time=2024-04-22, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2186628, encodeId=c9a52186628d1, content=偏重的研究方向：干细胞;干细胞治疗 经验分享：想知道投的这个杂志的综述容易接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=165a8423903, createdName=ms4000002111139793, createdTime=Fri Feb 09 00:47:43 CST 2024, time=2024-02-09, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2142719, encodeId=71fc2142e1908, content=投稿后10天左右让修改了一下格式，提交了原始图片，现在已经整整一个月了，一直处于 editor assigned状态，投稿时间记录..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85e38686630, createdName=ms8000000826346257, createdTime=Wed Jun 14 11:43:51 CST 2023, time=2023-06-14, status=1, ipAttribution=山西省)]

2023-06-14 ms8000000826346257 来自山西省

投稿后10天左右让修改了一下格式，提交了原始图片，现在已经整整一个月了，一直处于 editor assigned状态，投稿时间记录...

120 3

展开3条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务